M. D.Abu Bashar

57193518569

Publications - 2

Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023

Mohamad Amin Bakhshali Shoshana H. Ballew Ovidiu Constantin Baltatu Maciej Banach Mainak Bardhan Ahmed Abdelrahman Abdelgalil Saurav Basu Bekalu Mekonen Belay Makda Abate Belew Aminu K. Bello Luis Belo Amiel Nazer C. Bermudez Nurudeen A. Adegoke Fahmi Y. Al-Ashwal Nelson Alvis-Guzman Yaser Mohammed Al-Worafi Adel Sharaf Al-Zubairi Masoud Aman Mohammadi Hubert Amu Abhishek Anil Sajjad Ahmad Sulaimon O. Araromi Geminn Louis Carace Apostol Walter Appati Neeraj Bedi Filippos Anagnostakis Rizwan Suliankatchi Abdulkader Anayochukwu Edward Anyasodor Hiba Jawdat Barqawi Amir Mahmoud Ahmadzade Salah Al Awaidy Syed Shujait Ali Omar Almidani Hanadi Al Hamad Syed Mahfuz Al Hasan Karem H. Alzoubi Maha Moh'd Wahbi Atout Samar Abd Elhafeez Sajjad Ahmad Nesredin Ahmed Marjan Ajami Ayman Ahmed Salahdein Aburuz Yazan Al Thaher Ashagre Molla Assaye Khursheed Aurangzeb Adedapo Wasiu Awotidebe Domenico Azzolino Lucas Guimarães Abreu Bright Opoku Ahinkorah Qorinah Estiningtyas Sakilah Adnani Olugbenga Olusola Abiodun Dmitry Abramov Hasan Aalruz Qorinah Estiningtyas Sakilah Adnani Bilyaminu Abubakar Isaac Yeboah Addo Qorinah Estiningtyas Sakilah Adnani Oyelola A. Adegboye Muhammad Badar Mohammad Mahdi Bastan Akshaya Srikanth Bhagavathula Sonu Bhaskar M. D.Abu Bashar Shahid Bashir Temitayo Esther Adeyeoluwa Johan Ärnlöv Bernard Kwadwo Yeboah Asiamah-Asare Hasan Aalruz Patrick B. Mark Lauryn K. Stafford Morgan E. Grams Hansani Madushika Abeywickrama Mohammed Mehdi Abrar Khabir Ahmad Ali Ahmadi Aram Mahmood Ahmed Priyadarshini Bhattacharjee Jasvinder Singh Bhatti Salahdein Aburuz Aleksandr Y. Aravkin Mohammed Z. Allouh Mohammadreza Akbari Oluwasefunmi Akeju Mohammed Ahmed Akkaif Ziyad Al-Aly Mohammed Albashtawy Shereen M. Aleidi Ali M. Alfalki Fadwa Naji Alhalaiqa Khalid A. Alhasan Endale Alemayehu Ali Rafat Ali Syed Yusuf Ali Maha Moh d.Wahbi Atout Mohammed Z. Allouh Wesam Taher Almagharbeh Sadat Abdulla Aziz Khaldoon Aied Alnawafleh Awais Altaf Samah W. Al-Jabi Najim Z. Alshahrani Jesu Arockiaraj Rizwan Suliankatchi Abdulkader Shahzaib Ahmed Syed Anees Ahmed Yuni Asri Ajay Nagesh Bhat Sadat Abdulla Aziz

Publication Name: Lancet

Publication Date: 2025-11-22

Volume: 406

Issue: 10518

Page Range: 2461-2482

Description:

Background Chronic kidney disease (CKD) is common and ranks among the leading causes of mortality and morbidity. This analysis aimed to present global CKD estimates using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 to inform evidence-based policies for CKD identification and treatment. Methods This analysis focused on adults aged 20 years and older over the period 1990 to 2023, from 204 countries and territories. Data sources used were published literature, vital registration systems, kidney failure treatment registries, and household surveys. Estimates of CKD burden, including deaths, incidence, prevalence, and disability-adjusted life-years (DALYs), were produced using a Cause of Death Ensemble model and a Bayesian meta-regression analytical tool. A comparative risk assessment approach estimated the proportion of cardiovascular deaths attributable to impaired kidney function and estimated risk factors for CKD. Findings Globally, in 2023, 788 million (95% uncertainty interval 743–843) people aged 20 years and older were estimated to have CKD, up from 378 million (354–407) in 1990. The global age-standardised prevalence of CKD in adults was 14·2% (13·4–15·2), a relative rise of 3·5% (2·7–4·1) from 1990. The region with the highest age-standardised prevalence was north Africa and the Middle East (18·0%; 16·9–19·4). Most people had stage 1–3 CKD, with a combined prevalence of 13·9% (13·1–15·0). In 2023, CKD was the ninth leading cause of death globally, accounting for 1·48 million (1·30–1·65) deaths, and the 12th leading cause of DALYs, with an age-standardised DALY rate of 769·2 (691·8–857·4) per 100 000. Impaired kidney function as a risk factor accounted for 11·5% (8·4–14·5) of cardiovascular deaths. High fasting plasma glucose, body-mass index, and systolic blood pressure were all leading risk factors for CKD DALYs. Interpretation CKD is a major global health issue, with rising prevalence and increasing importance as a cause of death and as a risk factor for cardiovascular death. A better understating of aetiology, appropriate screening, and implementation programmes are needed to translate advances in CKD treatment into improved patient outcomes. Funding Gates Foundation, Wellcome, US National Kidney Foundation, and US National Institute of Diabetes and Digestive and Kidney Diseases.

Open Access: Yes

DOI: 10.1016/S0140-6736(25)01853-7

Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Amani Alansari Rana Kamal Abu Farha Haroon Ahmed Kamoru Ademola Adedokun Nurudeen A. Adegoke Aanuoluwapo Adeyimika Afolabi Lisa C. Adams Muayyad M. Ahmad Mesfin Abebe Armita Abedi Hubert Amu Anayochukwu Edward Anyasodor Aqeel Ahmad Mohmmad Minwer Alnaeem Williams Agyemang-Duah Alemwork Abie Muhammad Sohail Afzal Danish Ahmad Rotimi Felix Afolabi Saira Afzal Seyyed Shamsadin Athari Samar Abd Elhafeez Mehrunnisha Sharif Ahmed Ayman Ahmed Meriem Abdoun Zufishan Alam Lucas Guimarães Abreu Bright Opoku Ahinkorah Qorinah Estiningtyas Sakilah Adnani Haroon Ahmed Roberto Ariel Abeldaño Zuñiga Asma Ahmed Meshack Achore Hasan Aalruz Bilyaminu Abubakar Sawsan Abuhammad Olumide Abiodun Richard Gyan Aboagye Habeeb Omoponle Adewuyi Mohammad Mahdi Bastan M. D.Abu Bashar Shahid Bashir Oluwatobi E. Adegbile Olumide Thomas Adeleke Miracle Ayomikun Adesina Leticia Akua Adzigbli Hasan Aalruz Aleksandr Y. Aravkin Roberto Ariel Abeldaño Zuñiga Oli Ahmed Elizabeth Oluwatoyin Akin-Odanye Wole Akosile Idorenyin Ubon Akpabio Rasmieh Mustafa Al-Amer Turki M. Alanzi Shereen M. Aleidi Melaku Birhanu Alemu Fadwa Naji Alhalaiqa Hamid Alinejad Rokny Md Al-Mamun Joseph Uy Almazan Mohmmad Minwer Alnaeem Siddig Ibrahim Abdelwahab Babatope Oluwadamilare Adebiyi Makinde Adebayo Adeniyi Mohammad Sharif Ibrahim Alyahya Tarek Tawfik Amin Saeed Amini Sohrab Amiri Jimoh Amzat Asma Ahmed Montaha Al-Iede Intima Alrimawi Saeid Anvari David B. Anderson Luisa S. Flor Cory N. Spencer Jack Cagney Gabriela Fernanda Gil Yonas Abebe Boluwatife Stephen Anuoluwa Jorge Arias de la Torre Benedetta Armocida Alejandra Arrieta Deepavalli Arumuganainar Wesam Taher Almagharbeh Bilal Aslam Prince Atorkey Sachin R. Atre Abadi Hailay Atsbaha Madhu Sudhan Atteraya Ahmed Y. Azzam B. Sheeba Khlood K. Baghlaf Najim Z. Alshahrani Jose Balmori-de-la-Miyar Soham Bandyopadhyay Julie Alaere Atta Asma Ahmed Atif Amin Baig Manish Barik Suzanne Lyn Barker-Collo Azadeh Bashiri Tahira Ashraf Yuni Asri Wondu Feyisa Balcha

Publication Name: Lancet

Publication Date: 2026-01-03

Volume: 407

Issue: 10523

Page Range: 31-52

Description:

Background Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels. Methods We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor. Findings Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518–724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764–1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74–30·0) DALYs were attributed to IPV among females and 32·2 million (16·4–52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15–49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (–1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (–1·92 to 13·1) DALYs due to schizophrenia in 2023. Interpretation IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors. Funding Gates Foundation.

Open Access: Yes

DOI: 10.1016/S0140-6736(25)02503-6